Guillaume Passot
Guillaume Passot is an expert in Surgery at Centre Hospitalier Lyon Sud (France). Guillaume Passot has authored 335 publications, the most recent in 2026, and is an investigator in 20 clinical trials, 6 of them ongoing. SLR score: 1,062 (community average: 125). How the SLR is computed.
LeadR Profile
Surgery
Subspecialties: Oncology - Public Health - Hepatology
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 2009 - 2026
Number : 335
Citations
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Sensitive reverse transcription-digital droplet PCR-based discrimination of hepatitis delta virus RNAs reveals differential effects of interferon-α on viral RNA species. PMID 42842305 — cells, hepatitis d, hepatitis delta virus, rna, small interfering, reverse transcription, viruses, therapeutics, antiviral agents, hepatitis, rna, viral | J Gen Virol | 2026 | 0 |
| Outcomes of Long-Term Absorbable Mesh Use for Ventral Hernia Repair in Immunosuppressed Patients. PMID 42829876 — hernia, surgical wound infection, hernia, ventral, herniorrhaphy, immunosuppression therapy, infections, incisional hernia | World J Surg | 2026 | 0 |
| Patient-Specific Computational Model of Abdominal Wall Simulating Hernia Defect Closure to Predict Tension in the Posterior and Anterior Rectus Sheath. PMID 41811418 — hernia, aponeurosis, biomedical engineering, herniorrhaphy, dissection | Ann Biomed Eng | 2026 | 0 |
| Preoperative High-Dose Corticosteroids in Digestive Cancer Surgery: A Randomized Clinical Trial. PMID 42616512 — methylprednisolone, intraabdominal infections, surgical procedures, operative, adrenal cortex hormones, neoplasms, wound infection, infections, postoperative complications | JAMA Surg | 2026 | 1 |
| Impact of Tumor Multifocality on Outcomes Following Resection of Intrahepatic Cholangiocarcinoma: Implications for Future Staging Systems. PMID 42492585 — neoplasms, classification, therapeutics, cholangiocarcinoma, intrahepatic cholangiocarcinoma | J Natl Compr Canc Netw | 2026 | 0 |
Clinical Studies 20
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Cohort/Consortium Investigators 15
Ongoing Clinical Trials
6 ongoing trials started since 2021, where this expert is an investigator
Source: ClinicalTrials
| Study | Phase | Status | Start |
|---|---|---|---|
| metastatic colorectal cancer 2023-504831-42-00 — neoplasms, drug therapy, liver, neoplasm metastasis, therapeutics, colorectal neoplasms, chemotherapy | Phase 3 | Recruiting | 2025 |
| Surgical treatment of large incisional hernia with botulinum toxin A injection a double blind randomized controlled trial 2023-504554-35-00 — hernia, injections, botulinum toxins, type a, botulinum toxins, therapeutics, incisional hernia | Phase 3 | Recruiting | 2025 |
| Transorb Self Gripping Resorbable Mesh in High risk Subjects Undergoing Open Repair of Ventral Hernia NCT06449378 — hernia, hernia, abdominal, multiple chronic conditions, hernia, ventral, centers for disease control and prevention, u.s., prospective studies | N/A | Active not recruiting | 2024 |
| Neoadjuvant Chemotherapy for Obstructive Colon cancER First Treated by cOlostomy NCT06107920 — colostomy, neoplasms, colon, drug therapy, chemotherapy, adjuvant, neoadjuvant therapy, therapeutics, colectomy, colonic neoplasms, chemotherapy | Phase 3 | Recruiting | 2024 |
| Early Surgery Versus 3 Days Non surgical Management in Acute Small Bowel Obstruction (SURGI BOW) NCT06065150 — mortality, intestinal obstruction, treatment failure, laparoscopy, morbidity, therapeutics | N/A | Recruiting | 2024 |
LeadR Networks
Main global connection map